Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

<p>Representative metabolite concentration maps from the central slice derived from a series of dynamic 3D <sup>2</sup>H CSI images summed over the first 30 minutes of signal acquisition following [2,3-<sup>2</sup>H<sub>2</sub>]fumarate injection into A11 (&...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Friederike Hesse (14958870) (author)
অন্যান্য লেখক: Alan J. Wright (14931815) (author), Vencel Somai (14958873) (author), Flaviu Bulat (14958876) (author), Felix Kreis (14931818) (author), Kevin M. Brindle (9752021) (author)
প্রকাশিত: 2025
বিষয়গুলি:
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
_version_ 1849927639757750272
author Friederike Hesse (14958870)
author2 Alan J. Wright (14931815)
Vencel Somai (14958873)
Flaviu Bulat (14958876)
Felix Kreis (14931818)
Kevin M. Brindle (9752021)
author2_role author
author
author
author
author
author_facet Friederike Hesse (14958870)
Alan J. Wright (14931815)
Vencel Somai (14958873)
Flaviu Bulat (14958876)
Felix Kreis (14931818)
Kevin M. Brindle (9752021)
author_role author
dc.creator.none.fl_str_mv Friederike Hesse (14958870)
Alan J. Wright (14931815)
Vencel Somai (14958873)
Flaviu Bulat (14958876)
Felix Kreis (14931818)
Kevin M. Brindle (9752021)
dc.date.none.fl_str_mv 2025-11-24T22:42:22Z
dc.identifier.none.fl_str_mv 10.1158/0008-5472.30699281
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Figure_3_from_Imaging_Glioblastoma_Response_to_Radiotherapy_Using_sup_2_sup_H_Magnetic_Resonance_Spectroscopy_Measurements_of_Fumarate_Metabolism/30699281
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Methods and Technology
Imaging
Imaging probes
Magnetic resonance imaging (MRI)
Small animal imaging
dc.title.none.fl_str_mv Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Representative metabolite concentration maps from the central slice derived from a series of dynamic 3D <sup>2</sup>H CSI images summed over the first 30 minutes of signal acquisition following [2,3-<sup>2</sup>H<sub>2</sub>]fumarate injection into A11 (<b>B</b>, <b>C</b>, <b>E</b>, and <b>F</b>), S2 (<b>H</b>, <b>I</b>, <b>K</b>, and <b>L</b>), and U87 (<b>N</b>, <b>O</b>, <b>Q</b>, and <b>P</b>) tumor-bearing mice. The color code represents concentration (in mmol/L) derived from the ratios of the peak intensities in the malate and fumarate maps to peak intensities in an initial HDO map and corrected for the number of <sup>2</sup>H labels per molecule and for signal saturation. The locations of the tumors are indicated by dotted white lines determined from an underlying T<sub>2</sub>-weighted <sup>1</sup>H image acquired concurrently using a <sup>1</sup>H volume coil. The corresponding T<sub>2</sub>-weighted <sup>1</sup>H images were acquired separately at 9.4 T. The tumor locations are outlined with dotted black lines. T<sub>2</sub>-weighted <sup>1</sup>H images (<b>A</b>, <b>G</b>, and <b>M</b>) and the fumarate (<b>B</b>, <b>H</b>, and <b>N</b>) and malate (<b>C</b>, <b>I</b>, and <b>O</b>) concentration maps pretreatment and the corresponding T<sub>2</sub>-weighted <sup>1</sup>H images (<b>D</b>, <b>J</b>, and <b>P</b>) and the fumarate (<b>E</b>, <b>K</b>, and <b>Q</b>) and malate (<b>F</b>, <b>L</b>, and <b>R</b>) concentration maps 48 hours following the last chemoradiotherapy treatment.</p>
eu_rights_str_mv openAccess
id Manara_b5b1f2cd1702eb2d4cf6054b8050ff2e
identifier_str_mv 10.1158/0008-5472.30699281
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30699281
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate MetabolismFriederike Hesse (14958870)Alan J. Wright (14931815)Vencel Somai (14958873)Flaviu Bulat (14958876)Felix Kreis (14931818)Kevin M. Brindle (9752021)CancerMethods and TechnologyImagingImaging probesMagnetic resonance imaging (MRI)Small animal imaging<p>Representative metabolite concentration maps from the central slice derived from a series of dynamic 3D <sup>2</sup>H CSI images summed over the first 30 minutes of signal acquisition following [2,3-<sup>2</sup>H<sub>2</sub>]fumarate injection into A11 (<b>B</b>, <b>C</b>, <b>E</b>, and <b>F</b>), S2 (<b>H</b>, <b>I</b>, <b>K</b>, and <b>L</b>), and U87 (<b>N</b>, <b>O</b>, <b>Q</b>, and <b>P</b>) tumor-bearing mice. The color code represents concentration (in mmol/L) derived from the ratios of the peak intensities in the malate and fumarate maps to peak intensities in an initial HDO map and corrected for the number of <sup>2</sup>H labels per molecule and for signal saturation. The locations of the tumors are indicated by dotted white lines determined from an underlying T<sub>2</sub>-weighted <sup>1</sup>H image acquired concurrently using a <sup>1</sup>H volume coil. The corresponding T<sub>2</sub>-weighted <sup>1</sup>H images were acquired separately at 9.4 T. The tumor locations are outlined with dotted black lines. T<sub>2</sub>-weighted <sup>1</sup>H images (<b>A</b>, <b>G</b>, and <b>M</b>) and the fumarate (<b>B</b>, <b>H</b>, and <b>N</b>) and malate (<b>C</b>, <b>I</b>, and <b>O</b>) concentration maps pretreatment and the corresponding T<sub>2</sub>-weighted <sup>1</sup>H images (<b>D</b>, <b>J</b>, and <b>P</b>) and the fumarate (<b>E</b>, <b>K</b>, and <b>Q</b>) and malate (<b>F</b>, <b>L</b>, and <b>R</b>) concentration maps 48 hours following the last chemoradiotherapy treatment.</p>2025-11-24T22:42:22ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/0008-5472.30699281https://figshare.com/articles/figure/Figure_3_from_Imaging_Glioblastoma_Response_to_Radiotherapy_Using_sup_2_sup_H_Magnetic_Resonance_Spectroscopy_Measurements_of_Fumarate_Metabolism/30699281CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306992812025-11-24T22:42:22Z
spellingShingle Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
Friederike Hesse (14958870)
Cancer
Methods and Technology
Imaging
Imaging probes
Magnetic resonance imaging (MRI)
Small animal imaging
status_str publishedVersion
title Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
title_full Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
title_fullStr Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
title_full_unstemmed Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
title_short Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
title_sort Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
topic Cancer
Methods and Technology
Imaging
Imaging probes
Magnetic resonance imaging (MRI)
Small animal imaging